FDA places full, partial holds on durvalumab trialsSeptember 8, 2017Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive Lymphomas
Studies of donor CAR T cells placed on holdSeptember 6, 2017Leukemia, Myelodysplasia, TransplantationAML
FDA grants orphan designation to product for CMVSeptember 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
FDA grants orphan designation to product for GVHDSeptember 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Withdrawn AML drug back on market in USSeptember 2, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyAML
Nanocarriers could treat leukemia, lymphoma and improve HSCTSeptember 1, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationAggressive Lymphomas